Item 8.01. Other Events.
On June 11, 2014, Novavax, Inc. ("the Company") issued a press release
announcing the closing of the previously announced public offering of 25,000,000
shares of common stock (the "Offering"), and that, pursuant to the underwriting
agreement, dated June 5, 2014, with Citigroup Global Markets Inc. and J.P.
Morgan Securities LLC as representative of the several underwriters listed on
Schedule 1 thereto (the "Underwriters"), the Underwriters exercised their option
to purchase an additional 3,750,000 shares of the Company's common stock, $0.01
par value per share ("Common Stock"). A copy of the Company's press release is
attached hereto as Exhibit 99.1 and is incorporated herein by reference.
An opinion dated June 11, 2014 regarding the legality of the issuance of the
Common Stock in the Offering is filed as Exhibit 5.1 to this Current Report on
Item 9.01 Financial Statements and Exhibits
Exhibit No. Description
5.1 Opinion of Ropes & Gray LLP.
23.1 Consent of Ropes & Gray LLP (included in Exhibit 5.1 above).
99.1 Press Release of Novavax, Inc. dated June 11, 2014.